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Summary
QUESTION UNDER STUDY: In the first year after imple-
mentation of a public smoking ban a significant decrease
in the incidence of acute myocardial infarction (AMI) was
observed in Graubünden. In the present study we analyzed
the incidence of AMI in the second year of the ban. In addi-
tion, we investigated the contribution of smoking ban-un-
related factors to the reduced incidence of AMI incidence
observed after enactment of the ban.
METHODS: Data of all AMI patients who underwent
coronary angiography at the Kantonsspital Graubünden,
the only tertiary care hospital with a cardiac catheterization
laboratory in Graubünden, between March 1st, 2009 and
February 28th, 2010 were collected prospectively. Data
were compared with those of the three preceding 12-month
periods. We also estimated AMI incidence during the cor-
responding time period in Lucerne, a region with no
smoke-free legislation, using data of the AMIS Plus re-
gistry. The influence of outdoor air pollution was analyzed
with the help of official measurements of PM10- and NO2-
concentrations in Graubünden. The prescription of lipid-
lowering drugs was estimated by using sales figures in
Graubünden and Lucerne.
RESULTS: In Graubünden, the number of patients with
AMI in the second year after adoption of the smoking ban
was similar to that in the first year of the ban (188 vs.
183; P = ns) and significantly lower than in each of the
two years preceding the ban (229 and 242, respectively;
P <0.05 vs. each of the 12-month periods after the ban).
Overall, the number of AMI patients in the two post-ban
years was 21% lower than in the two pre-ban years. The
reduction in the number of patients with AMI was most
pronounced in non-smokers and individuals with known
coronary artery disease. During the corresponding time
period, no similar decrease in the incidence of AMI was
observed in Lucerne. No association was found between
the magnitude of outdoor air pollution and the incidence of
AMI. During the observation period, the use of lipid-lower-
ing drugs increased similarly in Graubünden and Lucerne.
CONCLUSIONS: Compared with the two years preceding
the implementation of a smoking ban, the incidence of
AMI remained significantly reduced in the second year of
the ban in Graubünden, whereas no similar reduction was
seen in a comparable area without smoke-free legislation.
Changes in outdoor air pollution or the use of lipid-lower-
ing drugs did not substantially contribute to the decrease
in the incidence of AMI that occurred after adoption of the
ban in Graubünden.
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Introduction
Passive smoking is associated with an increased risk of
coronary artery disease (CAD) and acute myocardial in-
farction (AMI) [1, 2]. Multiple studies in various countries
indicated that reducing the exposure to second hand smoke
(SHS) by implementation of regulations to ban smoking
in public buildings is followed by a rapid reduction in
the number of hospital admissions for acute coronary syn-
dromes [3–7]. In line with these studies, we observed a sig-
nificant decrease in the number of AMI patients admitted
to our hospital in the first year after smoke-free legisla-
tion had been adopted on March 1st, 2008 in the Canton
Graubünden, Switzerland [8].
However, despite the growing body of evidence from ob-
servational studies suggesting a beneficial effect of public
smoking bans on the risk of AMI, the proof of a causal re-
lationship between smoking bans and the reduction of AMI
rates observed after their implementation remains chal-
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lenging. Indeed, individual “before and after” studies are
hampered by the fact that time trends of acute coronary
syndrome incidence may be affected by various factors oth-
er than SHS exposure. Natural fluctuation of AMI rates, a
general trend towards a lower AMI risk over time, variation
of the size of the population at risk and changes in pre-
ventive measures (e.g. prevalence of lipid-lowering ther-
apy) represent examples for such smoking ban-unrelated
factors. Given the well-established association between air
pollution and cardiovascular events, a reduction in outdoor
particulate matter concentrations might also contribute to
the decrease in the incidence of AMI observed after enact-
ment of public smoking bans [9, 10].
Therefore, we performed the present analysis in order to
further elucidate the influence of such smoking ban-un-
related factors, including air pollution and lipid-lowering
therapy, on the incidence of AMI after implementation of
smoke-free legislation in Graubünden.
Patients and methods
Setting and study population in Graubünden
Details on the Canton Graubünden and its medical logistics
have been reported previously [8]. In brief, Graubünden
covers an area of 7106 km2 and has a resident population of
190,000. Graubünden represents the largest holiday destin-
ation of Switzerland, recording approximately six million
tourist overnight stays every year.
The Kantonsspital Graubünden serves as a tertiary care
hospital possessing the only cardiac catheterization labor-
atory in Graubünden and offers a 24-hour emergency ser-
vice for primary percutaneous coronary intervention for
AMI patients in Graubünden. Based on current treatment
guidelines, coronary angiography is recommended in all
patients with AMI. Given a well functioning network in-
cluding all hospitals of Graubünden and excellent trans-
portation capacities either by ambulance or by helicopter,
patients experiencing an AMI in Graubünden are trans-
ferred to the Kantonsspital Graubünden for either acute
(patients with STEMI or unstable patients with NSTEMI)
or early (other patients with NSTEMI) coronary angio-
graphy. Hence, the vast majority of AMI patients admitted
to one of the hospitals in Graubünden undergo coronary
angiography at the Kantonsspital Graubünden during their
index hospitalization. Therefore, the number of AMI pa-
tients undergoing coronary angiography at the Kantonsspit-
al Graubünden may be viewed as representative for the
overall incidence of AMI in Graubünden.
Data of all patients who suffered from an AMI in
Graubünden and underwent coronary angiography at the
Kantonsspital Graubünden within the first and second year
after implementation of the public smoking ban (between
March 1st, 2008 and February 28th, 2010) were collected
prospectively. These data were compared with those of all
patients who had suffered from an AMI in Graubünden and
had undergone coronary angiography at our hospital during
the two corresponding 12 month time periods preceding
implementation of the public smoking ban (between March
1st, 2006 and February 28th, 2007, and between March
1st, 2007 and February 29th, 2008, respectively), whereby
these patients were identified by their diagnoses at hos-
pital discharge (ICD-10 codes) and by analyzing various
local databases (coronary angiography database, intensive
care unit database). According to the universal definition
of myocardial infarction, AMI was defined as a detectable
level of cardiac troponin in a clinical setting consistent with
myocardial ischaemia [11].
Setting and study population at the comparison site
Lucerne
To investigate possible general temporal trends affecting
the incidence of AMI in Switzerland, we also assessed the
number of patients hospitalized because of AMI in the Can-
ton Lucerne. Importantly, in Lucerne no smoke-free legis-
lation existed until a nationwide regulation was enacted on
May 1st, 2010. The Canton Lucerne covers an area of 1493
km2 and has a resident population of 368,000.
To estimate the incidence of AMI in Lucerne, data of the
Acute Myocardial Infarction and Unstable Angina in
Switzerland (AMIS Plus) registry, a large nationwide pro-
spective registry of patients with acute coronary syndromes
admitted to Swiss hospitals, were used. The structure and
design of this registry have been reported recently [12].
Since January 1st, 2007, all three public hospitals in the
Canton Lucerne (LUKS Luzern, LUKS Sursee, LUKS
Wolhusen) participated in the AMIS Plus registry, provid-
ing comparison data on the incidence of AMI in Lucerne
for the last three 12 month observation time periods of our
study.
Assessment of air quality in Graubünden
As a measure of outdoor air pollution, concentrations of
particulate matter with an aerodynamic diameter of less
than 10 mm (PM10) and of nitrogen dioxide (NO2) are regu-
larly monitored by the Department of Nature and Environ-
ment (Amt für Natur und Umwelt Graubünden) at different
sites in Graubünden. For two distinct measuring sites loc-
ated at the main traffic axis (Chur and Rothenbrunnen) vir-
tually continuous data of daily PM10- and NO2-concentra-
tions since September 2006 are available (www.gr-luft.ch).
Based on these data, we estimated the magnitude of aver-
age monthly outdoor air pollution in Graubünden by calcu-
lating average concentrations of PM10 and NO2 for every
month from September 2006 to February 2010.
Assessment of sales figures of lipid lowering drugs
Data on sales figures of lipid-lowering drugs (statins, ez-
etimibe, fibrates, nicotinic acid, ion-exchange resins) in
Graubünden and Lucerne were provided by IMS Health
GmbH, Switzerland.
Statistical analysis
In order to compare the numbers of AMI cases between
the four 12 month time periods, 2 x 2 tables were set up to
check for equal distribution. Pearson’s correlation test was
used to investigate a possible relationship between monthly
incidence of AMI and the magnitude of average monthly
ambient air pollution. A P-value of <0.05 was considered
statistically significant. Statistical analyses were performed
using STATISTICA software, version 8.0 (StatSoft Inc.,
Tulsa, OK, USA).
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Results
In Graubünden, the number of patients with AMI in the
second year after adoption of the smoking ban was similar
to that in the first year of the ban and significantly lower
than in each of the two years preceding the ban (fig. 1).
Some of the data had already been published in our first
report [8]. Overall, the number of patients with AMI was
21% lower in the two years after implementation of the ban
compared with the two year period preceding the ban.
In contrast to Graubünden, no decrease in the incidence of
AMI was observed in Lucerne after March 1st 2008. On the
contrary, the number of AMI patients in Lucerne increased
during the two corresponding 12 month periods in which
the smoking ban was effective in Graubünden (fig. 1).
The number of myocardial infarctions in the four 12 month
study periods in various populations in Graubünden is
shown in figure 2. Similar to the first year (reported pre-
viously [8]), the decrease in the incidence of AMI in the
second year of the ban was limited to non-smokers, where-
as the number of smokers presenting with AMI was similar
before and after enactment of smoke-free legislation. The
number of female AMI patients showed a more pro-
nounced drop in the second year of the ban than during the
first year. In contrast, the magnitude of the decrease in the
incidence of AMI in male patients diminished in the second
year of the ban compared with the previous year. Over-
all, however, when compared with the average of the two
years preceding the ban a significant reduction in both male
(–18%; P <0.05) and female (-30%; P <0.05) AMI patients
could be observed in the 24 months following implementa-
tion of the ban. The numbers of resident patients with AMI
were virtually identical in both post-ban years. Population-
based incidences of AMI were 89.4, 93.8, 69.8, and 68.8
per 100000 residents in the four consecutive 12-month ob-
servation periods, respectively. On the other hand, the num-
ber of non-resident AMI patients was somewhat higher in
the second year after adoption of the ban compared with
the first post-ban year despite a similar number of visit-
or overnight stays in all 12 month observation periods (in-
dexed incidences of AMI in non-residents during the four
Figure 1
Numbers of myocardial infarctions in Graubünden (black bars) and
Lucerne (grey bars) in the year(s) before and the years after
implementation of a public smoking ban in Graubünden (dashed
line). Note that no data were available for Lucerne for the first
12-month period because not all public hospitals in Lucerne
participated in the AMIS Plus registry at that time. * P <0.05 vs.
each of the 2 previous 12-month periods in Graubünden. † P <0.05
vs. the previous 12-month period in Lucerne. ‡ P <0.05 vs. each of
the 2 previous 12-month periods in Lucerne.
12 month observation periods: 10.5, 10.8, 8.3, and 9.6 per
million visitor overnight stays). When taking both pre- and
post-ban 12 month observation periods together, overall re-
duction in AMI incidence was primarily caused by a signi-
ficant 23% decrease in the number of AMIs in the resident
population, whereas no significant reduction was present in
non-residents. In both post-ban years, the most pronounced
reduction in the number of AMIs was found in patients
with documented CAD, including those with prior AMI
and prior percutaneous coronary intervention and/or coron-
ary artery bypass graft surgery.
Markers of outdoor air pollution (PM10 and NO2) measured
in Graubünden showed typical annual variability with peak
values in the winter months during the entire observation
period (fig. 3). Overall, concentrations of air pollutants ten-
ded to slightly increase over the years. There was no rela-
tionship between the magnitude of monthly AMI rates and
average monthly PM10- or NO2-concentrations (r = 0.211,
P = 0.181 for PM10; r = 0.251, P = 0.109 for NO2).
Sales figures of lipid-lowering drugs increased similarly in
Graubünden and Lucerne during the study period (fig. 4).
Discussion
The present study extends and confirms our previous ob-
servation [8] of a significant decrease in the incidence of
AMI up to two years after the implementation of a public
smoking ban in Graubünden. Similar to the first year after
enactment of the ban, the decrease in the number of pa-
tients with AMI in the second year after introduction of
the ban was limited to non-smokers and the most pro-
nounced reduction was observed in individuals with estab-
lished CAD. Moreover, our results suggest that smoking
ban-unrelated factors such as natural variability of AMI in-
cidence, a general Swiss trend towards a lower incidence
of AMI over the last years, a reduction of the magnitude
of outdoor air pollution and prescription of lipid-lowering
drugs cannot explain the decrease in the incidence of AMI
Figure 2
Numbers of myocardial infarctions in various subpopulations in
Graubünden in the two 12-month periods before (3/2006 – 2/2007
and 3/2007 – 2/2008) and the two 12-month periods after (3/2008 –
2/2009 and 3/2009 – 2/2010) implementation of a public smoking
ban. * P <0.05 vs. each of the two 12-month periods preceding the
ban. CAD, coronary artery disease; AMI, acute myocardial
infarction; PCI, percutaneous coronary intervention; CABG,
coronary artery bypass graft surgery.
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observed after implementation of a public smoking ban in
Graubünden.
In our analysis we found that the number of patients with
AMI admitted to the Kantonsspital Graubünden was virtu-
ally identical in the first and the second year after imple-
mentation of the public smoking ban and was significantly
lower than in each of the two years preceding the adoption
of smoke-free legislation. Thus, the relatively stable AMI
rates in the two years before and the two years after imple-
mentation of the ban, respectively, suggest that the signific-
ant decrease in the number of AMI patients observed in the
first post-ban year [8] was not primarily caused by a more
pronounced natural annual fluctuation of AMI rates.
In order to rule out a general trend towards a decrease in
the incidence of AMI in Switzerland, we assessed the num-
ber of patients who were hospitalized with a diagnosis of
AMI between March 1st, 2007 and February 28th, 2010
in the Canton Lucerne, a Swiss area without smoke-free
legislation until May 1st, 2010. Based on data from the
AMIS Plus registry, an increase rather than a decrease in
the AMI incidence was found in Lucerne during the ob-
servation period, arguing against the presence of a gener-
al trend towards a lower incidence of AMI in Switzerland
during the last years.
Despite the well-known association between air pollution
and the risk of cardiovascular events [9, 10], we found no
relationship between the incidence of AMI and the mag-
nitude of outdoor PM10- or NO2-concentrations in our
study. However, it must be emphasized that although para-
meters of air quality were assessed along the main traffic
axis of Graubünden, Swiss national maximal daily limits
Figure 3
Average monthly outdoor concentrations of PM10 and NO2 in
Graubünden from September 2006 to February 2010. The dashed
lines show the overall trends in the concentrations of the respective
parameter over time.
Figure 4
Numbers of lipid-lowering drugs (counting units; tablets) sold in
Graubünden and Lucerne from March 2006 to February 2010. The
dashed lines show the overall trends in sales figures for the
respective region over time. (Data are courtesy of IMS Health
GmbH, Switzerland)
for PM10 (50 ug/m3) and NO2 (80 ug/m3) were only rarely
exceeded during the observation period. Thus, given the
rather low overall degree of air pollution observed during
the study period, it may be speculated that, compared with
urban areas, air pollution does not represent a major con-
tributor to the risk of AMI in rural and mountainous
Graubünden.
Dyslipidaemia represents one of the most important risk
factors for CAD and lipid-lowering therapy was convin-
cingly shown to reduce the risk of cardiovascular events
in both primary and secondary prevention [13, 14]. Thus,
it is conceivable that broadening the prescription of lipid-
lowering drugs would also translate into a decrease in the
incidence of AMI in the respective population. In
Graubünden, however, the sales figures of lipid-lowering
drugs increased slowly and steadily during the observation
period and there was no step-wise change in 2008, which
could explain the sudden decrease in the number of patients
with AMI observed after March 1st, 2008. Furthermore,
the fact that sales figures of lipid-lowering drugs showed
a similar increase during the same time period in Lucerne,
where no decrease in the incidence of AMI was noted,
argues against a correlation between the prescription rate
of lipid-lowering drugs and the decrease in the risk of
AMI observed after enactment of the smoking ban in
Graubünden.
Two recently published meta-analyses [3, 4] concluded that
there is a significant positive relationship between the dur-
ation of a smoking ban and the reduction in the incidence
of AMI. This conclusion was based on two US-studies
with a follow-up duration of three years [15, 16]. In our
study, no further reduction in the incidence of AMI was ob-
served in the second year of the ban. About the reasons for
this lack of an additional benefit with time can be specu-
lated. According to local authorities, compliance with the
smoking ban has been good since its implementation in
Graubünden on March 1st, 2008. However, given the con-
sistent but quite variable early benefit of smoking bans in
different populations [3], it is possible that population-de-
pendent factors might also affect the magnitude of the long-
term benefit of such bans. On the other hand, given the
rather small number of cases in our study, the possibil-
ity that slight natural fluctuations of AMI incidence might
have masked a further reduction in AMI incidence in the
second year of the ban must also be taken into account.
Our analysis has some limitations. First of all, it must be
emphasized that our observational results do not allow the
inference of a causal relationship between the implement-
ation of a smoking ban and the reduction of AMI incid-
ence observed thereafter. However, by ruling out a sub-
stantial effect of various smoking ban-unrelated factors on
the incidence of AMI in Graubünden and together with the
ever growing number of observational studies showing a
decrease in the rates of AMI after enactment of smoke-free
legislation all over the world, our results suggest that such
a relationship does, indeed, exist.
Our analysis is limited to a relatively small area and popu-
lation and, thus, a relatively low number of AMI cases. As
a consequence, small differences in the numbers of cases
among the different time periods may result in large per-
centage differences. Thus, the magnitude of the relative
reduction in the number of AMI patients overall and in
the various subgroups observed in the two years after im-
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plementation of the ban must be interpreted with caution.
However, it must also be emphasized that despite the rel-
atively low number of cases a statistically significant dif-
ference with regard to the number of AMI cases before and
after implementation of the ban was found even in some
rather small subgroups (e.g. patients with known CAD).
The incidence of AMI in Lucerne was estimated using data
of the AMIS Plus registry, a large, prospective national re-
gistry endorsed by the Swiss Societies of Cardiology, In-
ternal Medicine and Intensive Care [12]. The AMIS Plus
registry collects data on the whole spectrum of patients
with acute coronary syndrome from voluntarily participat-
ing hospitals of different sizes including all three public
hospitals in the Canton of Lucerne. Participating centres
are strongly encouraged to enrol all patients fulfilling the
inclusion criteria to avoid selection bias. However, given
the fact that participation is voluntary, a certain selection
bias cannot be ruled out. Thus, the absolute numbers of
AMIs reported in Lucerne must be interpreted with caution.
Nevertheless, the magnitude of the increase in the number
of patients with AMI in Lucerne over the last three 12
month periods in Lucerne argues against a general nation-
wide downward trend of AMI incidence during the last
years.
In summary, the results of the present analysis further sup-
port the assumption that the implementation of a public
smoking ban itself was the leading cause for the decrease
in the number of patients with AMI observed after adoption
of smoke-free legislation in Graubünden. Thus, together
with recently published data from Canada, England and
the USA [5–7], our data contribute to the growing body of
evidence indicating that reducing SHS exposure by imple-
mentation of public smoking bans represents an effective
method to reduce the risk of AMI in the general population.
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